Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
On this page, we’ll discuss Suboxone oral health side effects, the link between Suboxone and dental problems, how to manage Suboxone-related oral health issues, and much more.
Some of the common oral health side effects associated with Suboxone include:
If you have been prescribed Suboxone and are experiencing oral health side effects, it’s crucial to seek dental care and explore your legal options.
Contact Tru Law today using the chat on this page for a free case evaluation to discuss your Suboxone-related oral health concerns.
On this page, we’ll discuss an overview of Suboxone oral health side effects, outline the implications for dental health, delve into the FDA’s warnings about dental problems with buprenorphine, explore the specifics of transmucosal buprenorphine medicine, consider the impact of severe dental adverse events, and much more.
Suboxone, a medication used to treat opioid addiction, can lead to side effects impacting oral health.
Patients may experience various dental issues due to the method of medication administration, which typically involves dissolving the drug in the mouth.
Here are some common oral health challenges that patients taking Suboxone might encounter:
The FDA warns about dental problems regarding tooth decay stemming from medications containing buprenorphine, such as Suboxone, when taken orally.
They have reported occurrences of dental complications when the drug is completely dissolved in the mouth.
The FDA’s warning highlights several key points patients and healthcare providers should be aware of:
In the treatment of opioid use disorder (OUD), buprenorphine has become a key medication due to its efficacy and safety profile.
It serves as a steady foundation for successful recovery when used in medication-assisted treatment (MAT).
Buprenorphine is a partial opioid agonist that offers a range of benefits for individuals struggling with opioid overdose.
Here are some specific advantages:
Medication-assisted treatment combines buprenorphine medications with counseling and behavioral therapies.
This multifaceted approach is important for treating OUD:
Buprenorphine, a medication commonly used to treat opioid use disorder, has been linked to other oral health issues.
Even in individuals with previously good dental records, the risk of tooth problems persists when this medication is used.
Tooth decay and oral infections are notable concerns for patients using buprenorphine-based medications.
Here’s how these issues typically present:
Patients with no prior dental problems are not exempt from experiencing dental issues while on buprenorphine.
Key observations include:
The Food and Drug Administration (FDA) has updated requirements for prescribing treatment information regarding buprenorphine to adequately inform healthcare professionals and patients of potential oral health problems.
The FDA has imposed new warnings about the risk of severe dental problems for patients using buprenorphine.
These include a range of dental issues, from decay to oral sores.
Healthcare providers are now required to:
To ensure patient safety and well-being, the latest guidelines highlight the importance of dental health during medication use.
These new insights underscore the potential dental side effects of certain treatments.
Patients are also being provided with updated Medication Guides that:
Buprenorphine medication, while effective for opioid use disorder, can also lead to oral health challenges.
Patients should follow specific guidelines to preserve their dental health while undergoing suboxone treatment.
Buprenorphine should be continued as directed by a healthcare professional.
Stopping or altering the medication without guidance can lead to withdrawal symptoms and a potential relapse into opioid use.
To optimize treatment outcomes and maintain your health while on buprenorphine, consider the following advice:
It’s crucial for patients to take proactive steps to prevent oral health issues while using buprenorphine.
Here are measures to minimize dentistry concerns:
When prescribed buprenorphine, patients must prioritize their dental care.
This medication, while beneficial for treating opioid use disorder, has been linked to possible dental health complications.
Staying proactive about oral health can help mitigate these risks.
Healthcare providers must be fully informed about a patient’s oral health history before starting buprenorphine.
This transparency allows for:
It’s essential for patients on buprenorphine to schedule regular dentist visits.
This routine can help:
Regular dentist appointments and clear dialogue with healthcare professionals ensure patients receive the comprehensive dental care they need while managing their treatment.
When healthcare professionals prescribe buprenorphine, it’s essential to consider the potential oral health side effects.
Incorporating oral health assessments and referrals into the treatment plan helps manage these risks effectively.
When initiating buprenorphine treatment, it is crucial for healthcare providers to gain a comprehensive understanding of the patient’s dental history.
This initial step is vital to ensure that the treatment plan accommodates the patient’s specific oral health needs and concerns.
Healthcare professionals should:
Buprenorphine medicine may lead to dental issues; thus, an upfront assessment sets a foundation for preemptive dental care services.
Starting medications such as buprenorphine can have implications for oral health, necessitating close collaboration between healthcare providers and dental professionals.
Integrating dental care into the overall treatment plan is crucial to ensure patient well-being.
Upon prescribing buprenorphine, healthcare providers must:
Prompt dental referrals can prevent the development of severe oral health problems associated with buprenorphine use.
When treating patients who use buprenorphine, dental professionals play a crucial role in managing oral health risks.
Dentists should focus on early assessment and proactive measures to prevent dental decay.
Dentists should initiate caries risk assessment during the initial visit.
These evaluations are essential for establishing a patient’s current oral health status and identifying potential risks for dental decay due to buprenorphine use.
To ensure comprehensive care, dentists are advised to take the following steps during the evaluation process:
Creating preventive strategies is imperative to minimize the risk of extensive tooth decay for patients on buprenorphine.
To ensure optimal oral health, consider implementing the following preventive measures:
Individuals who have experienced tooth decay as a result of taking Suboxone may consider seeking legal advice to explore their rights for compensation through a personal injury lawsuit.
These legal actions might help recover costs for dental treatment, suffering, and any associated damages.
Buprenorphine, the active ingredient in Suboxone, can cause dry mouth, which reduces saliva production and may lead to increased dental problems such as tooth fracture and gum disease.
Additionally, buprenorphine medicines dissolved in the mouth can be particularly harmful to oral health.
There are typically statutes of limitations that apply to legal claims, which set deadlines for when a lawsuit must be filed.
Prospective plaintiffs should consult an attorney promptly to determine the deadline for joining a Suboxone dental lawsuit.
The compensation in legal cases related to Suboxone tooth decay varies and may include damages for dental treatment costs, pain and suffering, and lost wages.
Each case is unique, and the awarded compensation is determined based on the specific circumstances and severity of the dental issues.
While on Suboxone, it’s advisable to inform your dentist immediately about your medication, as certain dental procedures may require adjustments in your treatment.
For example, dental surgeries may necessitate a temporary change in Suboxone dosage to manage pain more effectively.
The most severe dental side effects reported from Suboxone use include tooth decay, severe cavities, oral infections, and tooth loss.
These can be significant and were reported even in patients with no history of dental issues, suggesting a strong linkage to the medication.
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
You can learn more about the Suboxone Lawsuit by visiting any of our pages listed below:
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
AFFF Lawsuit claims are being filed against manufacturers of aqueous film-forming foam (AFFF), commonly used in firefighting.
Claims allege that companies such as 3M, DuPont, and Tyco Fire Products failed to adequately warn users about the potential dangers of AFFF exposure — including increased risks of various cancers and diseases.
Suboxone Tooth Decay Lawsuit claims are being filed against Indivior, the manufacturer of Suboxone, a medication used to treat opioid addiction.
Claims allege that Indivior failed to adequately warn users about the potential dangers of severe tooth decay and dental injuries associated with Suboxone’s sublingual film version.
Social Media Harm Lawsuits are being filed against social media companies for allegedly causing mental health issues in children and teens.
Claims allege that companies like Meta, Google, ByteDance, and Snap designed addictive platforms that led to anxiety, depression, and other mental health issues without adequately warning users or parents.
Transvaginal Mesh Lawsuits are being filed against manufacturers of transvaginal mesh products used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).
Claims allege that companies like Ethicon, C.R. Bard, and Boston Scientific failed to adequately warn about potential dangers — including erosion, pain, and infection.
Bair Hugger Warming Blanket Lawsuits involve claims against 3M — alleging their surgical warming blankets caused severe infections and complications (particularly in hip and knee replacement surgeries).
Plaintiffs claim 3M failed to warn about potential risks — despite knowing about increased risk of deep joint infections since 2011.
Baby Formula NEC Lawsuit claims are being filed against manufacturers of cow’s milk-based baby formula products.
Claims allege that companies like Abbott Laboratories (Similac) and Mead Johnson & Company (Enfamil) failed to warn about the increased risk of necrotizing enterocolitis (NEC) in premature infants.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?